Maple Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $246K | Sell |
3,149
-967
| -23% | -$78K | 0.01% | 107 |
|
|
2026
Q1 | $357K | Sell |
4,116
-491
| -11% | -$47K | 0.02% | 90 |
|
|
2025
Q4 | $443K | Buy |
4,607
+323
| +8% | +$31.4K | 0.03% | 81 |
|
|
2025
Q3 | $408K | Sell |
4,284
-383
| -8% | -$35.2K | 0.03% | 86 |
|
|
2025
Q2 | $407K | Buy |
4,667
+1,652
| +55% | +$140K | 0.03% | 84 |
|
|
2025
Q1 | $271K | Sell |
3,015
-165
| -5% | -$14.8K | 0.02% | 102 |
|
|
2024
Q4 | $254K | Sell |
3,180
-385
| -11% | -$33.3K | 0.02% | 100 |
|
|
2024
Q3 | $321K | Sell |
3,565
-963
| -21% | -$81K | 0.02% | 92 |
|
|
2024
Q2 | $356K | Buy |
4,528
+78
| +2% | +$6.39K | 0.03% | 90 |
|
|
2024
Q1 | $388K | Sell |
4,450
-308
| -6% | -$26.3K | 0.04% | 79 |
|
|
2023
Q4 | $392K | Buy |
4,758
+378
| +9% | +$28.8K | 0.04% | 73 |
|
|
2023
Q3 | $343K | Buy |
4,380
+972
| +29% | +$81.4K | 0.04% | 77 |
|
|
2023
Q2 | $300K | Sell |
3,408
-106
| -3% | -$9.13K | 0.03% | 82 |
|
|
2023
Q1 | $283K | Sell |
3,514
-309
| -8% | -$25.2K | 0.03% | 81 |
|
|
2022
Q4 | $297K | Sell |
3,823
-523
| -12% | -$42.4K | 0.04% | 79 |
|
|
2022
Q3 | $360K | Sell |
4,346
-93,562
| -96% | -$8.41M | 0.05% | 74 |
|
|
2022
Q2 | $8.79M | Sell |
97,908
-6,893
| -7% | -$698K | 1.16% | 32 |
|
|
2022
Q1 | $11.6M | Sell |
104,801
-3,663
| -3% | -$387K | 1.37% | 29 |
|
|
2021
Q4 | $11.2M | Buy |
108,464
+5,001
| +5% | +$579K | 1.22% | 33 |
|
|
2021
Q3 | $13M | Buy |
103,463
+447
| +0.4% | +$57.9K | 1.65% | 27 |
|
|
2021
Q2 | $13.2M | Buy |
103,016
+6,516
| +7% | +$818K | 1.6% | 26 |
|
|
2021
Q1 | $11.4M | Buy |
96,500
+2,729
| +3% | +$320K | 1.69% | 29 |
|
|
2020
Q4 | $11M | Sell |
93,771
-113
| -0.1% | -$12.4K | 1.69% | 28 |
|
|
2020
Q3 | $10.6M | Buy |
93,884
+1,456
| +2% | +$146K | 1.71% | 25 |
|
|
2020
Q2 | $8.48M | Buy |
92,428
+1,386
| +2% | +$133K | 1.66% | 27 |
|
|
2020
Q1 | $8.21M | Buy |
91,042
+626
| +0.7% | +$66.6K | 2.05% | 21 |
|
|
2019
Q4 | $10.3M | Buy |
90,416
+3,099
| +4% | +$340K | 1.98% | 23 |
|
|
2019
Q3 | $9.48M | Buy |
87,317
+942
| +1% | +$98.3K | 2.04% | 22 |
|
|
2019
Q2 | $8.41M | Sell |
86,375
-471
| -0.5% | -$43K | 1.89% | 27 |
|
|
2019
Q1 | $7.91M | Buy |
86,846
+1,918
| +2% | +$172K | 1.86% | 27 |
|
|
2018
Q4 | $7.72M | Buy |
84,928
+1,346
| +2% | +$126K | 1.99% | 24 |
|
|
2018
Q3 | $8.22M | Buy |
83,582
+3,280
| +4% | +$303K | 1.85% | 23 |
|
|
2018
Q2 | $6.88M | Buy |
80,302
+36,084
| +82% | +$3.01M | 1.7% | 26 |
|
|
2018
Q1 | $3.55M | Buy |
44,218
+40,946
| +1,251% | +$3.38M | 0.88% | 40 |
|
|
2017
Q4 | $264K | Buy |
3,272
+10
| +0.3% | +$801 | 0.07% | 118 |
|
|
2017
Q3 | $254K | Hold |
3,262
| – | – | 0.07% | 124 |
|
|
2017
Q2 | $290K | Buy |
3,262
+52
| +2% | +$4.38K | 0.08% | 113 |
|
|
2017
Q1 | $259K | Buy |
+3,210
| New | +$251K | 0.08% | 116 |
|
|
2016
Q4 | – | Sell |
-3,074
| Closed | -$266K | – | 126 |
|
|
2016
Q3 | $266K | Buy |
+3,074
| New | +$268K | 0.09% | 109 |
|
|
2015
Q1 | – | Sell |
-3,240
| Closed | -$234K | – | 131 |
|
|
2014
Q4 | $234K | Buy |
+3,240
| New | +$225K | 0.08% | 118 |
|
Other funds holding MDT
Maple Capital Management's MDT Position: Q2 2026 in Review
Maple Capital Management reduced its Medtronic (MDT) stake by 23% in Q2 2026, selling an estimated $78K and leaving 3,149 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #107.
Maple Capital Management first reported a position in MDT in Q4 2014 and has held it in 40 quarters since. The position peaked at $13.2M in Q2 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Maple Capital Management held 3,149 shares of Medtronic worth $246K as of Q2 2026.
- Maple Capital Management sold 967 Medtronic shares in Q2 2026, an estimated $78K.
- Medtronic made up 0.01% of Maple Capital Management's portfolio in Q2 2026, its #107 holding.
- Maple Capital Management first reported a position in Medtronic in Q4 2014 and has held it in 40 quarters since.
- Maple Capital Management's Medtronic position peaked at $13.2M in Q2 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Maple Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.